Özkan, S. and Gezer, D. 2025. The impact of dapagliflozin on FIB-4 index over 2 years in patients with type 2 diabetes mellitus. The European Research Journal. 11, 4 (Jul. 2025), 676–682. DOI:https://doi.org/10.18621/eurj.1631079.